StageZero Life Sciences: Top 25 Undervalued Dividend Stocks on TSX (SZLS)
StageZero Life Sciences is now ranked among the top 25 undervalued small cap dividend-paying stocks on the Toronto Stock Exchange (TSX). A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). Medium, small, micro and nano group market capitalization (<10B).
All data provided as-at market close February 07, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Companies included above paid a dividend in the last 12-months. StageZero Life Sciences GeneNews Ltd is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. StageZero Life Sciences is listed under SZLS on the Toronto Stock Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| ELEF-T | Silver Elephant Mining | 0.47 | 0 | 0 | 0 | 0 | 0 |
| ATE-T | Antibe Therapeutics | 0.6 | 0 | 0 | 0 | 0 | 0 |
| THNC-T | Thinkific Labs | 2.36 | 0 | 0 | 0 | 0 | 0 |
| LPEN-T | Loop Energy | 1.01 | 0 | 0 | 0 | 0 | 0 |
| DII-A-T | Dorel Industries | 5.37 | 0 | 0 | 0 | 0 | 0 |
| VOYG-T | Voyager Digital | 0.34 | 0 | 0 | 0 | 0 | 0 |
| MOGO-T | Mogo | 1.15 | 0 | 0 | 0 | 0 | 0 |
| SZLS-T | StageZero Life Sciences | 0.07 | 0 | 0 | 0 | 0 | 0 |
| FLNT-T | FLINT | 0.04 | 0 | 0 | 0 | 0 | 0 |
| TBP-T | Tetra Bio Pharma | 0.03 | 0 | 0 | 0 | 0 | 0 |
| MOZ-T | Marathon Gold | 0.95 | 0 | 0 | 0 | 0 | 0 |
| ADCO-T | Adcore | 0.26 | 0 | 0 | 0 | 0 | 0 |
| VIVO-T | VIVO Cannabis | 0.03 | 0 | 0 | 0 | 0 | 0 |
| VQS-T | VIQ Solutions | 0.75 | 0 | 0 | 0 | 0 | 0 |
| IVQ-U-T | Invesque | 0.95 | 0 | 0 | 0 | 0 | 0 |
| IVQ-T | Invesque | 1.23 | 0 | 0 | 0 | 0 | 0 |
| CWEB-T | Charlottes Web Holdings | 0.7 | 0 | 0 | 0 | 0 | 0 |
| LSPK-T | LifeSpeak | 0.87 | 0 | 0 | 0 | 0 | 0 |
| WLLW-T | Willow Biosciences | 0.12 | 0 | 0 | 0 | 0 | 0 |
| TMD-T | Titan Medical | 0.41 | 0 | 0 | 0 | 0 | 0 |
| DII-B-T | Dorel Industries | 5.4 | 0 | 0 | 0 | 0 | 0 |
| SMT-T | Sierra Metals | 0.45 | 0 | 0 | 0 | 0 | 0 |
| PEA-T | Pieridae Energy | 0.84 | 0 | 3.7 | 0 | 0 | 0 |
| WM-T | Wallbridge Mining Co | 0.17 | 0 | 0 | 0 | 0 | 0 |
| IDG-T | Indigo Books & Music | 2.35 | 0 | 0 | 0 | 0 | 0 |
More about StageZero Life Sciences
Stocks in this category are held primarily for potential income and capital appreciation. Dividend stocks showing a higher valuation than their current price have both potential upside and ability to sustain or grow their dividend.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
